Skip to main content

Table 6 Description of antecedent statin use, if continued during admission and reason for discontinuation

From: Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching

Characteristic

Total cohort

Home statins documented

438 (47.5)

Continued inpatient statins

217 (49.5)

New inpatient statins

33 (13.2)

Reason for discontinued home statins

 Rhabdomyolysis

20 (9.2)

 Transaminitis

33 (15.2)

 Cannot tolerate oral medications

26 (12)

 Admission < 48 h

18 (8.3)

 Myalgias

3 (1.4)

 Cannot be determined

117 (53.9)

Reason for new inpatient statins

 NSTEMI

12 (36.4)

 Acute stroke

4 (12.1)

 New Heart Failure

1 (3)

 New diabetes

3 (9.1)

 Cannot be determined

13 (39.4)